Prelude Therapeutics Incorporated: Revision history

20 August 2022

• curprev 13:5513:55, 20 August 2022 95.149.241.133 talk 900 bytes +11 No edit summary undo

13 August 2022

• curprev 20:5820:58, 13 August 2022 109.180.50.163 talk 889 bytes +15 No edit summary undo

30 July 2022

• curprev 21:2121:21, 30 July 2022 172.18.0.2 talk 874 bytes +874 Created page with "Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-..."